COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1433: Articles 14321-14330  | Next

Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection
Drummer, H. E., Van, H., Klock, E., Zheng, S., Wei, Z., Boo, I., Center, R. J., Li, F., Bhat, P., Ffrench, R., Lau, J. S. Y., McMahon, J., Laeyendecker, O., Fernandez, R. E., Manabe, Y. C., Klein, S. L., Quinn, T. C., Anderson, D. A.
10.1101/2021.06.28.21259671 — Posted: 2021-07-01
COVID-19 Has Long Term Effects on Chemosensory Functions
Bussiere, N., Mei, J., Levesque-Boissonneault, C., Blais, M., Carazo, S., Gros-Louis, F., De Serres, G., Dupre, N., Frasnelli, J.
10.1101/2021.06.28.21259639 — Posted: 2021-07-01
Host cellular RNA helicases regulate SARS-CoV-2 infection
Ariumi, Y.
10.1101/2021.06.29.450452 — Posted: 2021-06-30
Computational saturation mutagenesis of SARS-CoV-1 spike glycoprotein: stability, binding affinity, and comparison with SARS-CoV-2
Sobitan, A., Mahase, V., Rhoades, R., Williams, D., Liu, D., Xie, Y., Li, L., Tang, Q., Teng, S.
10.1101/2021.06.30.450547 — Posted: 2021-06-30
Detection of potential new SARS-CoV-2 Gamma-related lineage in Tocantins shows the spread and ongoing evolution of P.1 in Brazil
Souza, U. J. B. d., Santos, R. N. d., Melo, F. L., Belmok, A., Galvao, J. D., Damasceno, S. B., Rezende, T. C. V. d., Andrade, M. d. S., Ribeiro, B. M., Ribeiro Junior, J. C., Carvalho, R. F., Oliveira, M. d. S., Santos, I. G. C. d., Spilki, F. R., Campos, F. S.
10.1101/2021.06.30.450617 — Posted: 2021-06-30
Exploitation of the Secretory Pathway by SARS-CoV-2 Envelope
Pearson, G. J., Broncel, M., Snijders, A. P., Carlton, J. G.
10.1101/2021.06.30.450614 — Posted: 2021-06-30
The SARS-CoV-2 host cell membrane fusion protein TMPRSS2 is a tumor suppressor and its downregulation correlates with increased antitumor immunity and immunotherapy response in lung adenocarcinoma
Liu, Z., Zhang, Z., Feng, Q., Wang, X.
10.1101/2021.06.30.450490 — Posted: 2021-06-30
Varenicline Prevents SARS-CoV-2 Infection In Vitro and in Rhesus Macaques
Nau, J., Luthra, P., Lanzer, K., Szaba, F., Cookenham, T., Carlson, E.
10.1101/2021.06.29.450426 — Posted: 2021-06-30
Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology
Belouzard, S., Machelart, A., Sencio, V., Vausselin, T., Hoffmann, E., Deboosere, N., Rouille, Y., Desmarets, L., Seron, K., Danneels, A., Robil, C., Belloy, L., Moreau, C., Piveteau, C., Biela, A., Vandeputte, A., Heumel, S., Deruyter, L., Dumont, J., Leroux, F., Engelmann, I., Alidjinou, E. K., Hober, D., Brodin, P., Beghyn, T., Trottein, F., Deprez, B., Dubuisson, J.
10.1101/2021.06.30.450483 — Posted: 2021-06-30
Pathology and immunity after SARS-CoV-2 infection in male ferrets is affected by age and inoculation route
van de Ven, K., van Dijken, H., Wijsman, L., Gomersbach, A., Schouten, T., Kool, J., Lenz, S., Roholl, P., Meijer, A., van Kasteren, P., de Jonge, J.
10.1101/2021.06.30.450298 — Posted: 2021-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).